[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.].;Neue Aspekte in der Therapie der neovaskulären altersabhängigen Makuladegeneration: Kriterien der Wiederbehandlung bei der Anti- VEGF Therapie.

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

Volumn 108, Issue 1, 2011, Pages 85-90

  Pauleikhoff, D ^a   Kirchhof, B ^a   Bertram, B ^a   Holz, F G ^a   Bartz Schmidt, U B ^a   Bornfeld, N ^a   Bresgen, M ^a   Heimann, H ^a   Helbig, H ^a   Horauf H ^a   Kampik, A ^a   Lemmen, K D ^a   Roider, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; DRUG ANTAGONISM; GERMANY; HUMAN; OPHTHALMOLOGY; PRACTICE GUIDELINE; RETINA MACULA DEGENERATION; STANDARD; SUBRETINAL NEOVASCULARIZATION;

ANTIBODIES, MONOCLONAL; BIOLOGICAL PRODUCTS; CHOROIDAL NEOVASCULARIZATION; GERMANY; HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGY; PRACTICE GUIDELINES AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955963354     PISSN: None     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-010-2326-1     Document Type: Article

References (0)